Use access key #2 to skip to page content.
$10.27 -0.63 (-5.78%)
1/9/2009 4:00 PM

Alkermes, Inc. (ALKS)

CAPS Rating:
****

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

View All Commentary (ALKS)

Recs

0

Avatar indyjoneses (99.79) Submitted: 8/28/08 12:11 PM : Outperform Start Price: $13.27 ALKS Score: 8.79

Irrational market beating for potential molecule, which may or may not have a non-existent problem. Should do well ihf/when Long Acting Byetta gets to the market

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links